Generate Life Sciences

What Generate Life Sciences does

Generate Life Sciences is a global life sciences company operating across the family-formation continuum from preconception through post-birth, with brands spanning donor gamete banking (California Cryobank, NW Cryobank, Donor Egg Bank USA), newborn stem cell storage (Cord Blood Registry, Cell Care), post-birth genetic screening (ReadyGen, in partnership with Sema4), and assisted reproductive technology distribution (Kitazato USA, DonorApplication.com). The company reports approximately 50% market share in the premium donor sperm category, 900,000+ newborn stem cell units in storage, 500+ sperm donors and 380+ egg donors, and a roster of 1,200+ IVF clinic customers served annually. Since founding in 1977, the company states it has helped nearly 1 million families and contributed to 75,000+ births.

The core technology stack is built around cryopreservation of reproductive cells (sperm, eggs) and newborn stem cells (cord blood and cord tissue), supplemented by Computer-Assisted Sperm Analysis (CASA) for motility and morphology evaluation. Cord Blood Registry pioneered cord tissue storage in 2010 for mesenchymal stem cells used in regenerative medicine applications, and 12 licensed genetic counselors support clinical interpretation services. Generate also serves as the exclusive U.S. distributor of Kitazato vitrification devices and related ART consumables, distributing into 40+ countries. Operations span eight U.S. locations (Los Angeles, Tucson, New York, Boston, Palo Alto, Rockville, among others) with international sites in Australia and Canada via the 2021 Cell Care Group acquisition, supported by 500+ employees.

The business model blends direct-to-consumer sales (donor sperm and eggs to individuals, cord blood and cord tissue storage to expectant families) with B2B distribution to fertility clinics and embryology laboratories. Revenue is generated through transaction fees on donor gametes and vitrification devices, and recurring subscription revenue from long-term newborn stem cell storage contracts renewed annually. All tissue banking operations are FDA-registered and AATB-accredited, with state licensure in California, New York, Illinois, and Maryland. Generate has operated as a wholly-owned subsidiary of CooperSurgical (CooperCompanies, NYSE: COO) since 2021.

Name

Generate Life Sciences

Legal name

Generate Life Sciences Co.

Website

https://generate.com

Company type

Private

Founded year

2020

Operating status

Acquired

Headcount range

101–250 employees

Short description

Generate Life Sciences provides donor sperm and egg banking, newborn stem cell storage, post-birth genetic screening, and ART device distribution through brands like California Cryobank and CBR. It serves 1,200+ IVF clinics and nearly one million families across the U.S., Canada, and Australia under parent CooperSurgical.

Ownership category

akta.pro rank

Product category

Reproductive and Cryobank Services

NAICS

Research and Development in Biotechnology (except Nanobiotechnology) (541714), Scientific Research and Development Services (5417), Biological Product (except Diagnostic) Manufacturing (325414)

SIC

In Vitro & In Vivo Diagnostic Substances (2835), Services-Commercial Physical & Biological Research (8731)

akta.pro industry

PRIMARYHLAAALAJ

Prenatal, Newborn & Reproductive Diagnostics (NIPT, IVF/PGT, newborn screening)

Healthcare & Life Sciences/Biotechnology & Biologics/Diagnostics (Biotech-related)

SECONDARYHLAFAMAH

Genetic & Prenatal Testing Laboratories

Healthcare & Life Sciences/Healthcare Providers & Systems/Clinical Laboratories

SECONDARYHLAAAGAA

Stem Cell–Based Regenerative Therapies

Healthcare & Life Sciences/Biotechnology & Biologics/Regenerative Medicine & Tissue Engineering

SECONDARYHLAAALAD

Genetic & Genomic Testing (germline, somatic, carrier, pharmacogenomics)

Healthcare & Life Sciences/Biotechnology & Biologics/Diagnostics (Biotech-related)

Keywords

• Reproductive services
• Cryopreservation services
• Newborn stem cell banking
• Donor sperm egg bank
• Fertility preservation

Headquarters

HQ city

Los Angeles

HQ country

United States

HQ region

North America

Offices6 records

Markets served

GTM type

B2B and B2C

Offering type

Services

Cost components

Personnel, Operations, Technology or R&D, Infrastructure, Marketing or Sales, Supply Chain

Revenue model

1. Reproductive Services (Donor Sperm & Egg): Sales of donor sperm and donor eggs to individuals and couples. California Cryobank holds 50% market share in premium donor sperm market. One of the largest reproductive services companies globally with 500+ sperm donors and 380+ egg donors.
2. Newborn Stem Cell Storage: Cord blood and tissue collection, processing, and storage services. 900K+ newborn stem cell units stored. Storage renewal accounts available online or over the phone.
3. Medical Device Distribution: Exclusive U.S. Distributor of Kitazato vitrification devices for IVF clinics.

Go-to-market motion3 records

Distribution channels4 records

Marketing channels4 records

Core offering

Generate Life Sciences is a global life sciences company that provides reproductive, newborn stem cell, and genetic services. Its core offerings include frozen donor sperm and egg banking through California Cryobank and Donor Egg Bank USA, cord blood and tissue storage through CBR, post-birth genetic screening via ReadyGen, and exclusive U.S. distribution of Kitazato vitrification devices to IVF clinics.

Product overview

Generate Life Sciences operates as a comprehensive life sciences platform offering reproductive, newborn stem cell, and genetic services. The company provides a unified portfolio consisting of California Cryobank (sperm and egg banking with 50% premium market share), CBR (largest U.S. newborn stem cell bank with 900K+ units), Donor Egg Bank USA, NW Cryobank, FamilyCord, Kitazato USA (vitrification device distribution), Donor Application, and ReadyGen. Services span from preconception (donor sperm/eggs, fertility preservation) through birth (cord blood/tissue banking) to post-birth (genetic screening). The company serves 1,200+ IVF clinics annually and has helped nearly 1 million families.

Differentiator

Problem solved

Functional benefit

Brands

• California Cryobank: Premier sperm and egg bank, one of the largest reproductive services companies globally with 50% market share in premium donor sperm market
• CBR (Cord Blood Registry)
• Donor Egg Bank USA
• NW Cryobank
• Kitazato USA
• Donor Application
• ReadyGen

Products and services

• California Cryobank
• CBR (Cord Blood Registry)
• Donor Egg Bank USA
• NW Cryobank
• Kitazato USA
• Donor Application
• ReadyGen

Quantifiable outcome

• 50% market share in premium donor sperm market
• +3 more outcomes

Named customers2 records

Segments5 records

Ideal customer profiles3 records

Technology focussed No

API detail

Has API

No

API docs

API detail

Core technology

AI maturity

App detail

Integration1 record

Feature3 records

Partnerships

Five partnerships are on record, tiered core, flagship and minor.

• Cell Care Group (Australia)coreStrategic or Co-development Partner · 2 June 2021Generate Life Sciences acquired Cell Care international cord blood banking group, comprising Cell Care in Australia, Insception Lifebank and Cells for Life in Canada, and Victoria Angel public bank. Expands operational footprint to three countries and adds 200,000+ cord blood and tissue samples.
• CooperSurgical (CooperCompanies)flagshipStrategic or Co-development Partner · 1 January 2021CooperSurgical, a recognized global leader in women's health and fertility solutions, completed acquisition of Generate Life Sciences. CooperSurgical is part of CooperCompanies (NYSE: COO). Announcement of acquisition made in 2021 with completion confirmed on the Generate website.
• NantKwestminorStrategic or Co-development Partner · 1 January 2020Cord Blood Registry (CBR) partnered with NantKwest to develop COVID-19 treatment using newborn stem cells. CBR established a biorepository for investigational studies in acute and persistent COVID-19.
• Sema4coreStrategic or Co-development Partner · 1 January 2019Generate launched ReadyGen post-birth genetic services in partnership with Sema4, expanding genetic screening offerings to families.
• KitazatocoreTechnology or Integration · 1 January 2018California Cryobank entered the medical device space with an exclusive distribution deal with Kitazato, becoming exclusive U.S. Distributor of the world's leading vitrification devices.

Scale indicators17 records

Recent moves7 records

Expansion highlights5 records

Direct peers

• Fairfax Cryobank: Major U.S. donor sperm bank and fertility tissue repository that competes head-to-head with California Cryobank for premium gamete sales to IVF clinics and individuals.
• Xytex: Donor sperm bank with a large international catalog, competing with California Cryobank in premium and identity-release donor segments.
• ViaCord: Cord blood and cord tissue banking service (Revvity/PerkinElmer) that competes directly with CBR for newborn stem cell storage enrollments.
• Cryos International: Global sperm and egg bank headquartered in Denmark, competing with California Cryobank for cross-border donor gamete shipments and IVF clinic distribution.
• Cryo-Cell International: One of the largest U.S. cord blood banking companies and a direct competitor to Generate's CBR business, also offering menstrual blood and other cellular storage services to families.

Emerging players

• TMRW Life Sciences: Technology-focused cryostorage platform for reproductive cells (IVF specimens) that could disintermediate traditional banks by offering automated, software-managed storage infrastructure.

Broad incumbents

• Genea Biomedx: Developer of IVF lab instruments and consumables (incubators, vitrification tools) competing in the same clinic-procurement channel where Generate's Kitazato line is sold.
• CooperSurgical: Generate's parent company and a global women's-health and fertility medical-device platform; pre-acquisition overlap in IVF consumables and devices made CooperSurgical both a partner and a comparable broad incumbent in the fertility ecosystem.
• Vitrolife: Global IVF media, consumables, and time-lapse incubator provider whose vitrification and culture media overlap with Kitazato USA's device business distributed by Generate.

Regional players

• European Sperm Bank: Denmark-based donor sperm bank focused on European and select international markets, comparable in catalog breadth and clinic distribution model but not directly overlapping in the U.S.

Market position

Strengths5 records

Weaknesses5 records

Competitive moat6 records

Key risks6 records

Key highlights7 records

Customer concentration

• Xx.com/generatelifesci
• Facebookfacebook.com/GenerateLifeSciences
• LinkedInlinkedin.com/company/generate-life-sciences
• Instagraminstagram.com/generatelifesciences

Compliance6 records

Revenue estimate

Valuation estimate

Number of profiles

Profiles7 records

Subsidiaries10 records

Funding overview

Funding rounds

Investors

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

M&A

Investments

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Frequently asked questions about Generate Life Sciences